Improved survival among females and association with lymphopenia in patients with newly diagnosed glioblastoma.
作者信息
Shi Diana D, Youssef Gilbert C, Nassar Amin H, Lim-Fat Mary Jane, Ligon Keith L, Wen Patrick Y, Rahman Rifaquat
机构信息
Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
出版信息
Neuro Oncol. 2022 Nov 2;24(11):2005-2007. doi: 10.1093/neuonc/noac190.
Abstract
摘要
相似文献
1
Improved survival among females and association with lymphopenia in patients with newly diagnosed glioblastoma.新诊断胶质母细胞瘤患者中女性生存率的提高及其与淋巴细胞减少的关联。
Neuro Oncol. 2022 Nov 2;24(11):2005-2007. doi: 10.1093/neuonc/noac190.
2
Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma.新诊断胶质母细胞瘤治疗诱导骨髓抑制的预后意义。
Neuro Oncol. 2022 Sep 1;24(9):1533-1545. doi: 10.1093/neuonc/noac070.
3
Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma.新诊断胶质母细胞瘤老年患者治疗相关淋巴细胞减少与总生存期的关系
J Neurooncol. 2016 Apr;127(2):329-35. doi: 10.1007/s11060-015-2037-1. Epub 2016 Jan 4.
4
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.西仑吉肽联合标准治疗用于伴有 MGMT 启动子甲基化的新诊断胶质母细胞瘤患者（CENTRIC EORTC 26071-22072 研究）：一项多中心、随机、开放标签、3 期临床试验。
Lancet Oncol. 2014 Sep;15(10):1100-8. doi: 10.1016/S1470-2045(14)70379-1. Epub 2014 Aug 19.
5
[Early postsurgical temozolomide treatment in newly diagnosed bad prognosis glioblastoma patients: Feasibility study].[新诊断的预后不良胶质母细胞瘤患者术后早期替莫唑胺治疗：可行性研究]
Bull Cancer. 2018 Jul-Aug;105(7-8):664-670. doi: 10.1016/j.bulcan.2018.05.006. Epub 2018 Jun 22.
6
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.替莫唑胺剂量密集疗法治疗新诊断的胶质母细胞瘤：一项随机 III 期临床试验。
J Clin Oncol. 2013 Nov 10;31(32):4085-91. doi: 10.1200/JCO.2013.49.6968. Epub 2013 Oct 7.
7
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.替莫唑胺剂量密集方案单药及联合异维甲酸、塞来昔布和/或沙利度胺用于胶质母细胞瘤的随机II期辅助析因研究
Neuro Oncol. 2015 Feb;17(2):266-73. doi: 10.1093/neuonc/nou155. Epub 2014 Sep 19.
8
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.化疗引起的淋巴细胞减少程度越大，增强的肿瘤特异性免疫反应就越能消除胶质母细胞瘤患者中表达 EGFRvIII 的肿瘤细胞。
Neuro Oncol. 2011 Mar;13(3):324-33. doi: 10.1093/neuonc/noq157. Epub 2010 Dec 10.
9
Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.胶质母细胞瘤同步放化疗后辅助替莫唑胺治疗的临床结局：单中心经验
Clin Neurol Neurosurg. 2009 Oct;111(8):679-82. doi: 10.1016/j.clineuro.2009.06.013. Epub 2009 Jul 28.
10
Glioblastoma survival in the United States before and during the temozolomide era.胶质母细胞瘤在美国替莫唑胺时代前后的生存情况。
J Neurooncol. 2012 Apr;107(2):359-64. doi: 10.1007/s11060-011-0749-4. Epub 2011 Nov 2.
引用本文的文献
1
A cross-sectional study examining the relationship between the advanced lung cancer inflammation index and prostate cancer.一项横断面研究，探讨晚期肺癌炎症指数与前列腺癌之间的关系。
J Health Popul Nutr. 2025 May 29;44(1):177. doi: 10.1186/s41043-025-00933-z.
2
Clinical significance of the advanced lung cancer inflammation index in gastrointestinal cancer patients: a systematic review and meta-analysis.晚期肺癌炎症指数在胃肠道癌患者中的临床意义：一项系统评价与荟萃分析
Front Oncol. 2023 Jun 19;13:1021672. doi: 10.3389/fonc.2023.1021672. eCollection 2023.
本文引用的文献
1
Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma.新诊断胶质母细胞瘤治疗诱导骨髓抑制的预后意义。
Neuro Oncol. 2022 Sep 1;24(9):1533-1545. doi: 10.1093/neuonc/noac070.
2
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials.癌症临床试验中接受免疫治疗、靶向治疗或化疗的患者发生严重不良事件的风险的性别差异。
J Clin Oncol. 2022 May 1;40(13):1474-1486. doi: 10.1200/JCO.21.02377. Epub 2022 Feb 4.
3
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.质子治疗降低胶质母细胞瘤患者发生高级别放射性淋巴细胞减少症的可能性：质子与光子的 II 期随机研究。
Neuro Oncol. 2021 Feb 25;23(2):284-294. doi: 10.1093/neuonc/noaa182.
4
Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data.基于患者影像、转录组和生存数据的分析揭示胶质母细胞瘤中的性别差异。
Sci Transl Med. 2019 Jan 2;11(473). doi: 10.1126/scitranslmed.aao5253.
5
Females have the survival advantage in glioblastoma.女性在胶质母细胞瘤中具有生存优势。
Neuro Oncol. 2018 Mar 27;20(4):576-577. doi: 10.1093/neuonc/noy002.
6
(133)Xe SPECT cerebral blood flow study in a healthy population: determination of T-scores.健康人群中（133）Xe单光子发射计算机断层扫描脑血流研究：T分数的测定
J Nucl Med. 2001 Jun;42(6):864-70.
Zotero 插件